Skip to main content

Overview

Dr. Karsten Suhre joined Weill Cornell Medicine-Qatar (WCM-Q) in March 2011 as Professor of Physiology and Biophysics and Director of the Bioinformatics Core.

From 2006 until joining WCM-Q, Dr. Suhre served as Professor in the Department of Biology at Ludwig-Maximilians-University in Munich (LMU), Germany. During that time, he also served as Group Leader for Metabolomics Research at the Institute for Bioinformatics and Systems Biology, Helmholtz Zentrum München, German Research Centre for Environmental Health. Before 2006, Dr. Suhre worked at the French National Centre for Scientific Research (CNRS) as a Director of Research.

Dr. Suhre's research interests focus on metabolomics and genetic epidemiology, bioinformatics, functional and structural biology. On these subjects, Dr. Suhre has taught multiple courses, published over seventy articles in peer-reviewed journals, and delivered numerous international presentations. 

Prior to joining WCM-Q, Dr. Suhre established the field of genome-wide association study of human metabolism, which is reflected in several high-impact publications in the field of which he is the senior author.

As a faculty member of WCM-Q since March 2011, Dr. Suhre’s now studies how genetic variation in human metabolism interacts with environmental challenges and lifestyle factors in the development of complex diseases, including diabetes, heart and kidney diseases. Knowledge of the genetic basis of metabolic individuality in humans generates many new hypotheses for biomedical and pharmaceutical research, and potentially informs individualized therapy. 

He is currently involved in setting up clinical studies in cooperation with different health organizations in Qatar, including diabetes and ovarian cancer, which centrally involve his specific knowledge in the field of metabolomics.

Highlights

  1. 1
    Cell genomics · 2024
    PMID: 38412862PMCID: PMC10943581DOIFirst and senior author57 citations
  2. 2
    Nature communications · 2024
    PMID: 38307861PMCID: PMC10837160DOIFirst author41 citations
  3. 3
    Nature communications · 2021
    PMID: 33627659PMCID: PMC7904950DOISenior author82 citations

Publications

334 publications

Funding

11 grants

Active

2 grants
  • Sub-PI
    Investigating gut metabolite markers and potential protective probiotic intervention in non-obese, apparently healthy individuals with insulin resistance
    Qatar National Research Fund · 2024–2027 · via Qatar University
    ARG01-0420-230007
  • Sub-PI
    Qatar Diabetes Prevention Program (QDPP)
    Qatar National Research Fund · 2019–2026 · via Hamad Medical Corporation
    NPRP11C-0115-180010
Completed grants (9)
  • Sub-PI
    Footprints of Insulin Sensitivity in Women From Arabic Ethnicity
    Qatar National Research Fund · 2021–2024 · via Hamad Medical Corporation
    IRGC-07-SI-20-745
  • PI
    Memorandum of Agreement - Services between WCMC and WCMC-Q campuses
    Weill Cornell Medical College · 2020–2020Contract
    SA 203114-01
  • PI
    Molecular characterization services on 350 of WCM-Q's serum samples for Dr Suhre's lab
    Leiden University Medical Center · 2018–2020Contract
    SA 183539-02
  • MPI
    Analysis of the inflammatory profile in childhood onset diabetes
    Sidra Medical and Research Center · 2018–2019Contract
    SMRC 190127-01
  • MPI
    Rational Metabolic Engineering as a New Tool for Targeted Intervention in Human Metabolism
    Qatar National Research Fund · 2016–2019
    NPRP 8-061-3-011
  • PI
    Core services agreement for Bioinformatics Core to provide services to Imperial College London
    Imperial College of London · 2018–2019Contract
    ICL 182926-01
  • PI
    Collaboration Agreement SIDRA and WCMQ
    Sidra Medical and Research Center · 2017–2018Contract
    SRA 192004
  • MPI
    Metabolomics Systems Biology Initiatives
    Weill Cornell Medical College/Qatar · 2017–2018Contract
    DUA 181891-01
  • KP
    Urine Metabolomics for the Noninvasive Diagnosis of Antibody Mediated Rejection in Kidney Allografts
    National Institute of Allergy and Infectious Diseases · 2016–2018
    R37AI051652-13

News mentions